Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Parini

Showing results (61-70 of 131) with videos related to

Pageof 14
Sort By:
Archives of Biochemistry and Biophysics|January 3, 2008
Hypocholesterolemic effects of fatty acid bile acid conjugates (FABACs) in miceAlicia Leikin-Frenkel, Paolo Parini, Fred M Konikoff, et al.
Physiological Genomics|November 13, 2003
Growth hormone-mediated alteration of fuel metabolism in the aged rat as determined from transcript profilesPetra Tollet-Egnell, Paolo Parini, Nina Ståhlberg, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivationChiara Degirolamo, Salvatore Modica, Michele Vacca, et al.
Molecular Pharmacology|July 14, 2007
Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyloxy]phenylacetic acid hydrochloride (GW3965)Pia Kotokorpi, Ewa Ellis, Paolo Parini, et al.
Journal of Lipid Research|May 13, 2010
HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liverCamilla Pramfalk, Zhao-Yan Jiang, Qu Cai, et al.
Plos One|December 11, 2013
The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient miceLisa-Mari Mörk, Stefan Rehnmark, Padideh Davoodpour, et al.
Circulation|August 28, 2002
Accumulation of foam cells in liver X receptor-deficient miceGertrud U Schuster, Paolo Parini, Ling Wang, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
Different regulation of the LXRalpha promoter activity by isoforms of CCAAT/enhancer-binding proteinsKnut R Steffensen, Gertrud U Schuster, Paolo Parini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 14, 2010
Prevalence and clinical implications of testosterone deficiency in men with end-stage renal diseaseJuan Jesús Carrero, Abdul Rashid Qureshi, Ayumu Nakashima, et al.
International Journal of Molecular Sciences|September 28, 2021
Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in <i>Pparg</i>-Null MiceMariano Schiffrin, Carine Winkler, Laure Quignodon, et al.
Pageof 14

Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Archives of Biochemistry and Biophysics|January 3, 2008
Hypocholesterolemic effects of fatty acid bile acid conjugates (FABACs) in miceAlicia Leikin-Frenkel, Paolo Parini, Fred M Konikoff, et al.
Physiological Genomics|November 13, 2003
Growth hormone-mediated alteration of fuel metabolism in the aged rat as determined from transcript profilesPetra Tollet-Egnell, Paolo Parini, Nina Ståhlberg, et al.
Hepatology (Baltimore, Md.)|June 24, 2014
Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivationChiara Degirolamo, Salvatore Modica, Michele Vacca, et al.
Molecular Pharmacology|July 14, 2007
Physiological differences between human and rat primary hepatocytes in response to liver X receptor activation by 3-[3-[N-(2-chloro-3-trifluoromethylbenzyl)-(2,2-diphenylethyl)amino]propyloxy]phenylacetic acid hydrochloride (GW3965)Pia Kotokorpi, Ewa Ellis, Paolo Parini, et al.
Journal of Lipid Research|May 13, 2010
HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liverCamilla Pramfalk, Zhao-Yan Jiang, Qu Cai, et al.
Plos One|December 11, 2013
The thyroid receptor modulator KB3495 reduces atherosclerosis independently of total cholesterol in the circulation in ApoE deficient miceLisa-Mari Mörk, Stefan Rehnmark, Padideh Davoodpour, et al.
Circulation|August 28, 2002
Accumulation of foam cells in liver X receptor-deficient miceGertrud U Schuster, Paolo Parini, Ling Wang, et al.
Biochemical and Biophysical Research Communications|June 11, 2002
Different regulation of the LXRalpha promoter activity by isoforms of CCAAT/enhancer-binding proteinsKnut R Steffensen, Gertrud U Schuster, Paolo Parini, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 14, 2010
Prevalence and clinical implications of testosterone deficiency in men with end-stage renal diseaseJuan Jesús Carrero, Abdul Rashid Qureshi, Ayumu Nakashima, et al.
International Journal of Molecular Sciences|September 28, 2021
Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in <i>Pparg</i>-Null MiceMariano Schiffrin, Carine Winkler, Laure Quignodon, et al.
Pageof 14